{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:04:25Z","timestamp":1792440265282,"version":"4.5.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Innate immune recognition plays a central role in determining the outcome of human papillomavirus (HPV) infection and the subsequent development of cervical cancer. This mini-review highlights how the reproductive tract\u2019s innate immune system, particularly Pattern Recognition Receptors (PRRs) such as Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), detects HPV-associated molecular patterns and initiates antiviral defenses. HPV has evolved sophisticated strategies to evade these responses by suppressing PRR signaling, altering cytokine networks, reprogramming cellular metabolism, and reshaping the cervical microenvironment. These viral mechanisms contribute to the formation of a persistent post-infection microenvironment (PIM), characterized by impaired antigen presentation, regulatory immune cell infiltration, chronic inflammation, and metabolic and stromal remodeling, which collectively promote immune tolerance and carcinogenesis. Emerging evidence also highlights the roles of inflammasomes, type I interferon pathways, and extracellular vesicles in modulating innate immune responses during HPV infection. Understanding how innate immunity senses HPV and how the virus circumvents these pathways provides crucial insight into cervical cancer progression and offers opportunities for developing more effective immunotherapies, vaccines, and prevention strategies. This review synthesizes current advances in HPV-driven innate immune dysregulation within the reproductive tract and their implications for reproductive immunology and infection-associated malignancy.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1758873","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:31:33Z","timestamp":1775539893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Innate immune recognition and microenvironmental reprogramming in HPV-induced cervical cancer: from pattern recognition receptor activation to immune tolerance disruption"],"prefix":"10.3389","volume":"16","author":[{"given":"Shahid Ullah","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, Dubai Medical University (COM, DMU)","place":["Dubai, United Arab Emirates"]},{"name":"Department of Animal Science, Faculty of Animal and Agricultural Sciences, Universitas Diponegoro. Jl. Prof. Jacub Rais","place":["Semarang, Central Java, Indonesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa H.","family":"Halawi","sequence":"additional","affiliation":[{"name":"Medical Laboratory Technology, College of Nursing and Health Sciences, Jazan University","place":["Jizan, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Almehmadi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University","place":["Taif, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan","family":"Taha","sequence":"additional","affiliation":[{"name":"Biology Department, Faculty of Science, King Khalid University","place":["Abha, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ezzat","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Biology Department, Faculty of Science, King Khalid University","place":["Abha, Saudi Arabia"]},{"name":"Prince Sultan Bin Abdelaziz for Environmental Research and Natural Resources Sustainability Center, King Khalid University","place":["Abha, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Y.","family":"Alfaifi","sequence":"additional","affiliation":[{"name":"Biology Department, Faculty of Science, King Khalid University","place":["Abha, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Shati","sequence":"additional","affiliation":[{"name":"Biology Department, Faculty of Science, King Khalid University","place":["Abha, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serag Eldin I.","family":"Elbehairi","sequence":"additional","affiliation":[{"name":"Biology Department, Faculty of Science, King Khalid University","place":["Abha, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, University of Kansas Medical Center","place":["Kansas, KS, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmene F.","family":"Alanazi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Rasheed","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, King Faisal University","place":["Al-Ahsa, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuruliarizki Shinta","family":"Pandupuspitasari","sequence":"additional","affiliation":[{"name":"Department of Animal Science, Faculty of Animal and Agricultural Sciences, Universitas Diponegoro. Jl. Prof. Jacub Rais","place":["Semarang, Central Java, Indonesia"]},{"name":"Food Research for Safety, Security, and Sustainability (FORC3S)","place":["Semarang, Indonesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endang","family":"Widiastuti","sequence":"additional","affiliation":[{"name":"Faculty of Animal and Agricultural Sciences, Universitas Diponegoro","place":["Semarang, Central Java, Indonesia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir Ullah","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, IQRA University Chak","place":["Islamabad, Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12885-020-07150-3","article-title":"Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis","volume":"20","author":"Azevedo Martins","year":"2020","journal-title":"BMC Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191811641","article-title":"Radical hysterectomy for early stage cervical cancer","volume":"19","author":"Bogani","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/cmr.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.7150\/jca.21444","article-title":"Clinical significance of CD163+ and CD68+ tumor-associated macrophages in high-risk HPV-related cervical cancer","volume":"8","author":"Chen","year":"2017","journal-title":"J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2023.2230666","article-title":"Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment","volume":"12","author":"Chen","year":"2023","journal-title":"Oncoimmunology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3857\/roj.2018.00500","article-title":"Management for locally advanced cervical cancer: new trends and controversial issues","volume":"36","author":"Cho","year":"2018","journal-title":"Radiat. Oncol. J."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004232","article-title":"ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response","volume":"10","author":"De Sousa","year":"2022","journal-title":"J. ImmunoTher Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.990877","article-title":"Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer","volume":"12","author":"Ding","year":"2022","journal-title":"Front. Oncol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030646","article-title":"The interplay between antiviral signalling and carcinogenesis in human papillomavirus infections","volume":"12","author":"Ferreira","year":"2020","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"v403","DOI":"10.1093\/annonc\/mdx376.002","article-title":"Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer","volume":"28","author":"Glisson","year":"2017","journal-title":"Ann. Oncol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/cancers14030575","article-title":"Management of early-stage cervical cancer: a literature review","volume":"14","author":"Guimar\u00e3es","year":"2022","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40425-019-0526-z","article-title":"Efficacy of PD-1 blockade in cervical cancer is related to a CD8+ FoxP3+ CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels","volume":"7","author":"Heeren","year":"2019","journal-title":"J. ImmunoTher Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftz048","article-title":"Association of human papillomavirus infection and inflammation in cervical cancer","volume":"77","author":"Hemmat","year":"2019","journal-title":"Pathog. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41418-023-01242-w","article-title":"Activating STING\/TBK1 suppresses tumor growth via degrading HPV16\/18 E7 oncoproteins in cervical cancer","volume":"31","author":"Huang","year":"2024","journal-title":"Cell Death Differ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10.1128\/msphere. 00828","DOI":"10.1128\/msphere.00828-19","article-title":"Human papillomavirus 16 E6 and E7 synergistically repress innate immune gene transcription","volume":"5","author":"James","year":"2020","journal-title":"Msphere"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.979884","article-title":"Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003384","article-title":"Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response","volume":"9","author":"Karim","year":"2013","journal-title":"PloS Pathog."},{"key":"B18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12935-024-03513-z","article-title":"Curcumin attenuates smoking and drinking activated NF-\u03baB\/IL-6 inflammatory signaling axis in cervical cancer","volume":"24","author":"Kashyap","year":"2024","journal-title":"Cancer Cell Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.21873\/invivo.12143","article-title":"Review of innovative physical therapy methods: Introduction to the principles of cold physical plasma","volume":"34","author":"Kletschkus","year":"2020","journal-title":"In Vivo"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/v16010113","article-title":"HPV16 E6 oncogene contributes to cancer immune evasion by regulating PD-L1 expression through a miR-143\/HIF-1a pathway","volume":"16","author":"Konstantopoulos","year":"2024","journal-title":"Viruses"},{"key":"B21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13167-021-00244-3","article-title":"The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer","volume":"12","author":"Kudela","year":"2021","journal-title":"Epma J."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1645019","article-title":"HPV infection and the immune microenvironment in cervical cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jog.16247","article-title":"The efficacy of anti\u2010angiogenic drugs in gastric\u2010type endocervical adenocarcinoma: a retrospective study","volume":"51","author":"Li","year":"2025","journal-title":"J. Obstetrics Gynaecology Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215205","article-title":"Role of immunotherapy in the treatment of cancer: a systematic review","volume":"14","author":"Ling","year":"2022","journal-title":"Cancers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s44178-024-00113-9","article-title":"Efficacy and safety of immunotherapy in cervical cancer: a review of advances in immune-related therapy for cervical cancer","volume":"4","author":"Liu","year":"2025","journal-title":"Holistic Integr. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.annonc.2024.10.002","article-title":"Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study","volume":"36","author":"Lorusso","year":"2025","journal-title":"Ann. Oncol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28310","article-title":"DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS\u2010STING\u2010triggered innate immune activation","volume":"95","author":"Lou","year":"2023","journal-title":"J. Med. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16\u2013related cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz8235","article-title":"Strong vaccine responses during chemotherapy are associated with prolonged cancer survival","volume":"12","author":"Melief","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1586\/14737140.2016.1121108","article-title":"Immunotherapy and targeted therapy for cervical cancer: an update","volume":"16","author":"Menderes","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112508","article-title":"Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway","volume":"42","author":"Miyauchi","year":"2023","journal-title":"Cell Rep."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/nu14245273","article-title":"Resveratrol against cervical cancer: evidence from in vitro and in vivo studies","volume":"14","author":"Nadile","year":"2022","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41591-020-01225-1","article-title":"TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers","volume":"27","author":"Nagarsheth","year":"2021","journal-title":"Nat. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/01.ogx.0001004660.29812.17","article-title":"Cervical cancer screening: a review","volume":"330","author":"Perkins","year":"2023","journal-title":"Jama"},{"key":"B35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13337-022-00776-w","article-title":"HPV18 oncoproteins driven expression of PKM2 reprograms HeLa cell metabolism to maintain aerobic glycolysis and viability","volume":"33","author":"Prakasam","year":"2022","journal-title":"Virusdisease"},{"key":"B36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-024-01958-4","article-title":"Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response","volume":"23","author":"Qi","year":"2024","journal-title":"Mol. Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/v14071361","article-title":"Human beta papillomavirus type 8 E1 and E2 proteins suppress the activation of the RIG-I-Like receptor MDA5","volume":"14","author":"Rattay","year":"2022","journal-title":"Viruses"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207622","article-title":"IRF-1 inhibits angiogenic activity of HPV16 E6 oncoprotein in cervical cancer","volume":"21","author":"Rho","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10156-012-0485-5","article-title":"Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer","volume":"18","author":"Sasagawa","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1685931","article-title":"The cGAS-STING signaling pathway: emerging targets and challenges in breast cancer immunotherapy","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca: A Cancer J. For. Clin."},{"key":"B42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/01635581.2025.2474260","article-title":"The impact of oral nutrition supplementation and dietary education on nutritional status, knowledge, attitudes, and behaviour in cancer patients: a randomized clinical trial","volume":"77","author":"Syahruddin","year":"2025","journal-title":"Nutr. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamaoncol.2023.5410","article-title":"Pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer: subgroup analyses from the KEYNOTE-826 randomized clinical trial","volume":"10","author":"Tewari","year":"2024","journal-title":"JAMA Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1158\/1078-0432.ccr-15-2594","article-title":"Vaccination against oncoproteins of HPV16 for noninvasive vulvar\/vaginal lesions: lesion clearance is related to the strength of the T-cell response","volume":"22","author":"van Poelgeest","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ygyno.2023.04.028","article-title":"Randomized phase II BGOG\/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer","volume":"174","author":"Vergote","year":"2023","journal-title":"Gynecologic Oncol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02896","article-title":"Involvement of human papillomaviruses in cervical cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00427-23","article-title":"Interactions among human papillomavirus proteins and host DNA repair factors differ during the viral life cycle and virus-induced tumorigenesis","volume":"8","author":"Wendel","year":"2023","journal-title":"Msphere"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e2","article-title":"Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study","volume":"31","author":"Xiao","year":"2020","journal-title":"J. Gynecologic Oncol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.984896","article-title":"Immune checkpoint inhibitors in cervical cancer: current status and research progress","volume":"12","author":"Xie","year":"2022","journal-title":"Front. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cac2.12629","article-title":"Advances in cervical cancer: current insights and future directions","volume":"45","author":"Xu","year":"2025","journal-title":"Cancer Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/s1470-2045(20)30486-1","article-title":"Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial","volume":"21","author":"Youn","year":"2020","journal-title":"Lancet Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2020.10.034","article-title":"HPV post-infection microenvironment and cervical cancer","volume":"497","author":"Yuan","year":"2021","journal-title":"Cancer Lett."},{"key":"B53","first-page":"312","article-title":"HPV E6\/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer","volume":"6","author":"Zhang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9182979","article-title":"Human papillomavirus type 16 disables the increased natural killer cells in early lesions of the cervix","volume":"2019","author":"Zhang","year":"2019","journal-title":"J. Immunol. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41392-024-02083-w","article-title":"Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010092","article-title":"Advancing the fight against cervical cancer: the promise of therapeutic HPV vaccines","volume":"13","author":"Zheng","year":"2025","journal-title":"Vaccines"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1758873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:31:36Z","timestamp":1775539896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1758873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":56,"alternative-id":["10.3389\/fcimb.2026.1758873"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1758873","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"article-number":"1758873"}}